Loading clinical trials...
Loading clinical trials...
A Randomised Trial of Chlorambucil Versus Fludarabine as Initial Therapy of Waldenström's Macroglobulinaemia and Splenic Lymphoma With Villous Lymphocytes
Conditions
Interventions
chlorambucil
fludarabine phosphate
+1 more
Locations
49
Australia
Canberra Hospital
Garran, Australian Capital Territory, Australia
Newcastle Mater Misericordiae Hospital
Waratah, New South Wales, Australia
Princess Alexandra Hospital
Brisbane, Queensland, Australia
Queen Elizabeth Hospital
Woodville, South Australia, Australia
Peter MacCallum Cancer Centre
East Melbourne, Victoria, Australia
Stoke Mandeville Hospital
Aylesbury-Buckinghamshire, England, United Kingdom
Start Date
June 1, 2006
Primary Completion Date
December 1, 2009
Completion Date
January 1, 2013
Last Updated
August 26, 2013
NCT05139017
NCT06263491
NCT06337318
NCT07388563
NCT05529069
NCT06189391
Lead Sponsor
Taunton and Somerset Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions